AI assistant
Sending…
Glucotrack, Inc. — Director's Dealing 2025
Oct 8, 2025
35378_dirs_2025-10-07_bf7fada6-1273-47d0-9c0c-bed6e9462497.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Glucotrack, Inc. (GCTK)
CIK: 0001506983
Period of Report: 2025-03-25
Reporting Person: Balo Andrew K (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-03-25 | Common Stock, par value $0.001 per share | A | 75 | — | Acquired | 75 | Direct |
| 2025-07-11 | Common Stock, par value $0.001 per share | A | 3332 | — | Acquired | 3407 | Direct |
| 2025-10-03 | Common Stock, par value $0.001 per share | A | 1285 | — | Acquired | 4692 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-10-03 | Stock option (right to buy) | $7.4 | A | 4055 | Acquired | 2035-10-03 | Common Stock, par value $0.001 per share (4055) | Direct |
Footnotes
F1: Each option grant has a vesting commencement date of July 1 of the applicable calendar year and vests in 12 equal monthly installments over the 12-month period ending June 30 of the following year, subject to the reporting person's continued service to the Issuer through each vesting date.
More from Glucotrack, Inc.
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 14
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 14
Annual Report
2026
Mar 30
Regulatory Filings
2026
Mar 27
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Proxy Solicitation & Information Statement
2026
Feb 9
Regulatory Filings
2026
Jan 29